東北大学加齢医学研究所　臨床腫瘍学分野　東北大学　腫瘍内科

研究室紹介

HOME < 研究業績 < 英文論文 2018年度

英文論文 2018年度

  1. Denda, T.，Sakai, D.，Hamaguchi, T.，Sugimoto, N.，Ura, T.，Yamazaki, K.，Fujii, H.，Kajiwara, T.，Nakajima, T. E.，Takahashi, S.，Otsu, S.，Komatsu, Y.，Nagashima, F.，Moriwaki, T.，Esaki, T.，Sato, T.，Itabashi, M.，Oki, E.，Sasaki, T.，Sunaga, Y.，Ziti-Ljajic, S.，Brillac, C.，Yoshino, T.: Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer. Cancer Sci 110. 1032-1043. Mar （2019）
  2. Narita, K.，Sayar, N.，Saijo, K.，Ishioka, C.，Katoh, T.: A Concise Approach for Producing Optically Pure Carboxylic Acid Segments for the Synthesis of Bicyclic Depsipeptide Histone Deacetylase Inhibitors　Synthesis 51. 1408–1418. Feb（2019）
  3. Ishida, H.，Kasajima, A.，Onodera, Y.，Konno, T.，Maruyama, S.，Okamoto, H.，Sato, C.，Heishi, T.，Sakurai, T.，Taniyama, Y.，Takahashi, M.，Fujishima, F.，Jingu, K.，Ishioka, C.，Sasano, H.，Kamei, T.: A comparative analysis of clinicopathological factors between esophageal small cell and basaloid squamous cell carcinoma. Medicine (Baltimore) 98. e14363. Feb（2019）
  4. Yoshino, Y.，Qi, H.，Kanazawa, R.，Sugamata, M.，Suzuki, K.，Kobayashi, A.，Shindo, K.，Matsuzawa, A.，Shibata, S.，Endo, S.，Miyanishi, Y.，Shimaoka, T.，Ishioka, C.，Kanno, S. I.，Yasui, A.，Chiba, N.: RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells. Oncogene Jan 7（2019）
  5. Kikuchi, K.，Nozawa, K.，Yamazaki, N.，Nakai, Y.，Higashiyama, A.，Asano, M.，Fujiwara, Y.，Kanda, S.，Ohe, Y.，Takashima, A.，Boku, N.，Inoue, A.，Takahashi, M.，Mori, T.，Taguchi, O.，Inoue, Y.，Mizutani, H.: Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption. J Dermatol 46. 18-25. Jan（2019）
  6. Watanabe, T.，Mikami, M.，Katabuchi, H.，Kato, S.，Kaneuchi, M.，Takahashi, M.，Nakai, H.，Nagase, S.，Niikura, H.，Mandai, M.，Hirashima, Y.，Yanai, H.，Yamagami, W.，Kamitani, S.，Higashi, T.: Quality indicators for cervical cancer care in Japan. J Gynecol Oncol 29. e83. Nov（2018）
  7. Yoshino, Y.，Qi, H.，Fujita, H.，Shirota, M.，Abe, S.，Komiyama, Y.，Shindo, K.，Nakayama, M.，Matsuzawa, A.，Kobayashi, A.，Ogoh, H.，Watanabe, T.，Ishioka, C.，Chiba, N.: BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number. Mol Cancer Res 16. 1499-1511. Oct（2018）
  8. Toriyama, K.，Hijioka, S.，Komoto, I.，Kobayashi, N.，Okusaka, T.，Ku, Y.，Sudo, K.，Furukawa, M.，Tachibana, Y.，Takahashi, M.，Yasuda, H.，Nakamori, S.，Honma, Y.，Kida, M.，Fujimori, N.，Kashiwada, T.，Masui, T.，Ishii, H.，Tsuchiya, Y.，Ito, T.: Study Protocol for Prospective Observational Study 1 on the Prognosis of Patients with Unresectable Advanced Gastrointestinal and Pancreatic Neuroendocrine Tumors (PROP-UP 1 Study) in Japan. Journal of Clinical Trials 08. Oct 24（2018）
  9. Sunami, K.，Takahashi, H.，Tsuchihara, K.，Takeda, M.，Suzuki, T.，Naito, Y.，Sakai, K.，Dosaka-Akita, H.，Ishioka, C.，Kodera, Y.，Muto, M.，Wakai, T.，Yamazaki, K.，Yasui, W.，Bando, H.，Fujimoto, Y.，Fukuoka, S.，Harano, K.，Kawazoe, A.，Kimura, G.，Koganemaru, S.，Kogawa, T.，Kotani, D.，Kuboki, Y.，Matsumoto, H.，Matsumoto, S.，Mishima, S.，Nakamura, Y.，Sawada, K.，Shingaki, S.，Shitara, K.，Umemoto, K.，Umemura, S.，Yasuda, K.，Yoshino, T.，Yamamoto, N.，Nishio, K.: Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0). Cancer Sci 109. 2980-2985. Sep（2018）
  10. Imai, H.，Saijo, K.，Komine, K.，Kawamura, Y.，Hiraide, S.，Umegaki, S.，Okada, Y.，Ohuchi, K.，Sato, Y.，Takahashi, M.，Takahashi, S.，Shirota, H.，Takahashi, M.，Ishioka, C.: Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer. Cancer Manag Res 10. 3629-3636. Sep 17（2018）
  11. Ouchi, K.，Takahashi, S.，Chikamatsu, S.，Ito, S.，Takahashi, Y.，Kawai, S.，Okita, A.，Kasahara, Y.，Okada, Y.，Imai, H.，Komine, K.，Saijo, K.，Takahashi, M.，Shirota, H.，Takahashi, M.，Gamoh, M.，Ishioka, C.: Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors. Int J Clin Oncol 23. 790-798. Aug（2018）
  12. Oishi, T.，Sato, K.，Morita, T.，Mack, J. W.，Shimodaira, H.，Takahashi, M.，Takahashi, S.，Inoue, A.，Murakawa, Y.，Kawahara, M.，Ishioka, C.，Miyashita, M.: Patient perceptions of curability and physician-reported disclosures of incurability in Japanese patients with unresectable/recurrent cancer: a cross-sectional survey. Jpn J Clin Oncol, Aug 9（2018）
  13. Sato, Y.，Miyashita, M.，Sato, K.，Fujimori, K.，Ishikawa, K. B.，Horiguchi, H.，Fushimi, K.，Ishioka, C.: End-of-life care for cancer patients in Japanese acute care hospitals: A nationwide retrospective administrative database survey. Jpn J Clin Oncol, Aug 13（2018）
  14. Okita, A.，Imai, H.，Takahashi, M.，Takahashi, H.，Umegaki, S.，Kawamura, Y.，Hiraide, S.，Ouchi, K.，Sato, Y.，Okada, Y.，Komine, K.，Saijo, K.，Takahashi, S.，Takahashi, M.，Shirota, H.，Ohori, H.，Gamoh, M.，Ishioka, C.: Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis. Tohoku J. Exp. Med. 245. 123-129. June（2018）
  15. Kato, S.，Imai, H.，Gamoh, M.，Takahata, T.，Ohori, H.，Yasuda, K.，Niitani, T.，Murakawa, Y.，Amagai, K.，Isobe, H.，Shindo, Y.，Kuroki, M.，Sakamoto, Y.，Shimodaira, H.，Yoshioka, T.，Ishioka, C.: Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study. Tohoku J Exp Med 245. 21-28. May（2018）
  16. Okita, A.，Takahashi, S.，Ouchi, K.，Inoue, M.，Watanabe, M.，Endo, M.，Honda, H.，Yamada, Y.，Ishioka, C.: Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer. Oncotarget 9. 18698-18711. 2 April 10（2018）

ページの先頭へ戻る

© 2006 Department of Medical Oncology, Tohoku University Hospital All rights reserved.